Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time
Reportable, Inc.: Anticancer Bioscience Presenting at Biotech Showcase Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Anticancer Bioscience is participating in Biotech Showcase Digital 2021. The Company will showcase its pioneering approach to precision oncology, and how it is applying its synthetic lethality expertise for better cancer therapies. The Company has five distinct synthetic lethality programs in drug development. Click image a...
Source: finanznachrichten.de